• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

F-FDG PET/CT in multiple myeloma: critical insights and future directions.

作者信息

Bailly Clément, Carlier Thomas, Jamet Bastien, Touzeau Cyrille, Moreau Philippe, Kraeber-Bodéré Françoise, Bodet-Milin Caroline

机构信息

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Department of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France.

出版信息

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1048-1050. doi: 10.1007/s00259-019-04279-7. Epub 2019 Feb 15.

DOI:10.1007/s00259-019-04279-7
PMID:30770949
Abstract
摘要

相似文献

1
F-FDG PET/CT in multiple myeloma: critical insights and future directions.18F-FDG PET/CT在多发性骨髓瘤中的应用：关键见解与未来方向
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1048-1050. doi: 10.1007/s00259-019-04279-7. Epub 2019 Feb 15.
2
Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.[F]FDG-PET/CT 在异基因造血细胞移植前后多发性骨髓瘤患者中的预后价值。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1694-1704. doi: 10.1007/s00259-018-3997-0. Epub 2018 Apr 2.
3
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.多发性骨髓瘤患者接受诱导化疗和自体造血干细胞移植后标准化 FDG-PET 参数的预后意义：一项回顾性单中心评估。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27.
4
Dual assessment with multiparameter flow cytometry and F-FDG PET/CT scan provides enhanced prediction of measurable residual disease after autologous haemopoietic stem cell transplant in myeloma-a prospective study.多参数流式细胞术和F-FDG PET/CT扫描的双重评估可增强对骨髓瘤患者自体造血干细胞移植后可测量残留病的预测——一项前瞻性研究。
Bone Marrow Transplant. 2023 Sep;58(9):1045-1047. doi: 10.1038/s41409-023-02017-0. Epub 2023 Jun 16.
5
Treatment response evaluation with F-FDG PET/CT and F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.使用F-FDG PET/CT和F-NaF PET/CT对接受大剂量化疗和自体干细胞移植的多发性骨髓瘤患者进行治疗反应评估。
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):50-62. doi: 10.1007/s00259-016-3502-6. Epub 2016 Aug 29.
6
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.18F-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描相结合在评估接受异基因干细胞移植的多发性骨髓瘤患者中的作用。
Biol Blood Marrow Transplant. 2015 Jun;21(6):1068-73. doi: 10.1016/j.bbmt.2015.03.001. Epub 2015 Mar 6.
7
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).FDG PET/CT 多发性骨髓瘤解读标准（IMPeTUs）：最终结果。IMPeTUs（意大利多发性骨髓瘤 PET 使用标准）。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.
8
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为多发性骨髓瘤预后的预测指标
PET Clin. 2019 Jul;14(3):383-389. doi: 10.1016/j.cpet.2019.03.005. Epub 2019 Apr 19.
9
[Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].[（18）F-FDG PET/CT在新诊断的多发性骨髓瘤患者中的预后价值]
Zhonghua Yi Xue Za Zhi. 2019 Jan 22;99(4):301-306. doi: 10.3760/cma.j.issn.0376-2491.2019.04.013.
10
Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.F-FDG PET/CT 在多发性骨髓瘤和其他浆细胞疾病的诊断和管理中的作用：国际骨髓瘤工作组的共识声明。
Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.

引用本文的文献

1
The ratio of brain to liver glucose activity and disease activity in multiple myeloma.多发性骨髓瘤中脑与肝脏葡萄糖活性及疾病活性的比率。
Blood Cancer J. 2025 May 7;15(1):90. doi: 10.1038/s41408-025-01280-2.
2
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.AZD3965（一种单羧酸转运蛋白 1 抑制剂）在晚期癌症患者中的 I 期剂量递增研究。
Clin Cancer Res. 2023 Apr 14;29(8):1429-1439. doi: 10.1158/1078-0432.CCR-22-2263.

本文引用的文献

1
Utility and prognostic value of F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma.初诊多发性骨髓瘤患者 F-FDG 正电子发射断层扫描/计算机断层扫描的效用和预后价值。
Am J Hematol. 2018 Dec;93(12):1518-1523. doi: 10.1002/ajh.25279. Epub 2018 Oct 2.
2
F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System.F-FDG PET/CT 对于使用修订后的国际分期系统（Revised International Staging System）分类为 II 期和 III 期的多发性骨髓瘤患者的生存结局的判断具有重要价值。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):107-115. doi: 10.1007/s00259-018-4114-0. Epub 2018 Sep 5.
3
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.一线治疗多发性骨髓瘤的 PET 中期分析：IMAJEM 研究中 FDG 摄取患者的 ΔSUVmax 的预后价值。
Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1.
4
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.多发性骨髓瘤患者接受诱导化疗和自体造血干细胞移植后标准化 FDG-PET 参数的预后意义：一项回顾性单中心评估。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27.
5
Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.[F]FDG-PET/CT 在异基因造血细胞移植前后多发性骨髓瘤患者中的预后价值。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1694-1704. doi: 10.1007/s00259-018-3997-0. Epub 2018 Apr 2.
6
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).FDG PET/CT 多发性骨髓瘤解读标准（IMPeTUs）：最终结果。IMPeTUs（意大利多发性骨髓瘤 PET 使用标准）。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.
7
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.多区域测序揭示的多发性骨髓瘤中的空间基因组异质性
Nat Commun. 2017 Aug 16;8(1):268. doi: 10.1038/s41467-017-00296-y.
8
Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.IFM/DFCI 2009试验中纳入的有症状多发性骨髓瘤患者在诊断时及维持治疗前进行磁共振成像和[F]氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描的前瞻性评估：IMAJEM研究结果
J Clin Oncol. 2017 Sep 1;35(25):2911-2918. doi: 10.1200/JCO.2017.72.2975. Epub 2017 Jul 7.
9
Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.F-FDG PET/CT 在多发性骨髓瘤和其他浆细胞疾病的诊断和管理中的作用：国际骨髓瘤工作组的共识声明。
Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.
10
Report of the 6th International Workshop on PET in lymphoma.第六届淋巴瘤正电子发射断层显像国际研讨会报告
Leuk Lymphoma. 2017 Oct;58(10):2298-2303. doi: 10.1080/10428194.2017.1298752. Epub 2017 Mar 7.